Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Roles of Matrix Metalloproteinase-9 in Cancer Metastasis

  • Kang, Hyereen (Department of Biomedical Sciences, University of Ulsan College of Medicine) ;
  • Jang, Sung-Wuk (Department of Biomedical Sciences, University of Ulsan College of Medicine)
  • Received : 2014.05.29
  • Accepted : 2014.08.20
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They are multidomain proteins and their activities are regulated by tissue inhibitor of metalloproteinases (TIMPs). The uncontrolled regulation of MMPs is involved in various pathologic processes, such as tumor invasion, migration, host immune escape, extravasation, angiogenesis, and tumor growth. Especially, matrix metalloproteinase-9 (MMP-9) is one of the metastasis-accelerating genes involved in metastasis of various types of human cancers. Here, we review the member of MMP family and discusses their domain structure and function, enzyme activation, the mechanism of inhibition by TIMPs. In particular, we focus the role of MMP-9 in relation to cancer metastasis.

Keywords

References

  1. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002. 115: 3719-3727. https://doi.org/10.1242/jcs.00063
  2. Bernhard EJ, Hagner B, Wong C, Lubenski I, Muschel RJ. The effect of E1A transfection on MMP-9 expression and metastatic potential. Int J Cancer. 1995. 60: 718-724. https://doi.org/10.1002/ijc.2910600525
  3. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol. 1995. 7: 728-735. https://doi.org/10.1016/0955-0674(95)80116-2
  4. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993. 4: 197-250. https://doi.org/10.1177/10454411930040020401
  5. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005. 1755: 37-69.
  6. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000. 1477: 267-283. https://doi.org/10.1016/S0167-4838(99)00279-4
  7. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol. 1996. 3: 895-904. https://doi.org/10.1016/S1074-5521(96)90178-7
  8. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006. 25: 9-34. https://doi.org/10.1007/s10555-006-7886-9
  9. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002. 2: 161-174. https://doi.org/10.1038/nrc745
  10. Farina AR, Mackay AR. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. Cancers (Basel). 2014. 6: 240-296. https://doi.org/10.3390/cancers6010240
  11. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011. 278: 16-27. https://doi.org/10.1111/j.1742-4658.2010.07919.x
  12. Groblewska M, Siewko M, Mroczko B, Szmitkowski M. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. Folia Histochem Cytobiol. 2012. 50: 12-19. https://doi.org/10.5603/FHC.2012.0002
  13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000. 100: 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  14. Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 1996. 56: 5279-5284.
  15. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst. 2002. 94: 1134-1142. https://doi.org/10.1093/jnci/94.15.1134
  16. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis. 1999. 17: 177-181. https://doi.org/10.1023/A:1006603723759
  17. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999. 31: 34-45. https://doi.org/10.3109/07853899909019260
  18. Kim JW, Wong CW, Goldsmith JD, Song C, Fu W, Allion MB, Herlyn M, Al-Mehdi AB, Muschel RJ. Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. Cancer Lett. 2004. 213: 203-212. https://doi.org/10.1016/j.canlet.2004.03.042
  19. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol. 2000. 157: 1777-1783. https://doi.org/10.1016/S0002-9440(10)64815-8
  20. Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol. 2009. 34: 881-895.
  21. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002. 70: 561-573. https://doi.org/10.1046/j.1432-0436.2002.700909.x
  22. MacDougall JR, Bani MR, Lin Y, Muschel RJ, Kerbel RS. 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer. 1999. 80: 504-512. https://doi.org/10.1038/sj.bjc.6690385
  23. Morrison CJ, Butler GS, Bigg HF, Roberts CR, Soloway PD, Overall CM. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem. 2001. 276: 47402-47410. https://doi.org/10.1074/jbc.M108643200
  24. Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer. 2008. 8: 929-941.
  25. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006. 69: 562-573. https://doi.org/10.1016/j.cardiores.2005.12.002
  26. Nakajima M, Welch DR, Wynn DM, Tsuruo T, Nicolson GL. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res. 1993. 53: 5802-5807.
  27. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007. 8: 341-352.
  28. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res. 2005. 11: 5158-5166. https://doi.org/10.1158/1078-0432.CCR-04-2478
  29. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004. 4: 448-456. https://doi.org/10.1038/nrc1370
  30. Piperi C, Papavassiliou AG. Molecular mechanisms regulating matrix metalloproteinases. Curr Top Med Chem. 2012. 12: 1095-1112. https://doi.org/10.2174/1568026611208011095
  31. Ram M, Sherer Y, Shoenfeld Y. 2006. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol. 2012. 26: 299-307.
  32. Roeb E, Matern S. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors]. Z Gastroenterol. 2001. 39: 807-813. https://doi.org/10.1055/s-2001-17197
  33. Sehgal G, Hua J, Bernhard EJ, Sehgal I, Thompson TC, Muschel RJ. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol. 1998. 152: 591-596.
  34. Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem. 1989. 264: 11539-11542.
  35. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000. 10: 415-433. https://doi.org/10.1006/scbi.2000.0379
  36. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001. 17: 463-516. https://doi.org/10.1146/annurev.cellbio.17.1.463
  37. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002. 37: 375-536. https://doi.org/10.1080/10409230290771546
  38. Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013. 48: 222-272. https://doi.org/10.3109/10409238.2013.770819
  39. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003. 92: 827-839. https://doi.org/10.1161/01.RES.0000070112.80711.3D
  40. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997. 91: 439-442. https://doi.org/10.1016/S0092-8674(00)80429-8